• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » University of Oklahoma buys biomarker generator

University of Oklahoma buys biomarker generator

March 2, 2011
CenterWatch Staff

The University of Oklahoma's student newspaper, The Oklahoma Daily, reported the school's college of pharmacy will acquire a biomarker generator from Tennessee-based Advanced Biomarker Technologies (ABT).

The University stated it "will be the first institution in the world to install and use a biomarker generator for help in imaging and diagnosing diseases," according to a report in Fierce Biotech.

ABT's website says the biomarker generator is composed of two technologies: a shielded table-top cyclotron for producing the positron emitting isotopes of C-11 and F-18, plus a flow microchemistry subsystem for labeling specific molecules with the positron emitting isotopes. The system is unique, according to ABT, because it is about 10 times smaller than other PET cyclotrons and is easy to install.

"This is the first, smallest one that has been named as a biomarker generator," Vibhudutta Awasthi, college of pharmacy researcher and professor, told the Oklahoma Daily. "Because of its simplicity, it can produce biomarkers on demand. If a patient is in the clinic and that patient needs an imaging study using a certain biomarker, you can push the button and within 30 to 40 minutes you can have a dose for that patient."

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing